Assessment of Weight-bearing Ankle Range of Motion Using the Ankle Test and Lower Body Test and I… (NCT07589218) | Clinical Trial Compass
RecruitingNot Applicable
Assessment of Weight-bearing Ankle Range of Motion Using the Ankle Test and Lower Body Test and Its Relationship With Ligamentous Hyperlaxity in Child Basketball Players Aged 8 to 15 Years
Spain38 participantsStarted 2025-12-09
Plain-language summary
This research aims to complement existing podiatric studies by providing information on the relationship between ligamentous hyperlaxity, a benign condition more frequently found in the pediatric population, and ankle range of motion in child basketball players aged 8-15. Furthermore, this hyperlaxity will allow us to correlate it with the most frequent type of injury experienced by the participants and assess whether future research could develop a prevention plan for this population and extrapolate it to more professional categories.
Who can participate
Age range
8 Years – 15 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects within the age range specified in the study.
* Signed and fully completed parental consent form.
* Participation in basketball as a sport twice a week, not including school physical education, or a total of 3 hours per week.
Exclusion Criteria:
* Subjects with injuries or any musculoskeletal impairment relevant to the measurement of the parameters to be evaluated.
* Any temporary illness that prevents the participant from being in full physical condition.
* Disorders related to loss of balance due to vestibular, cognitive, or cerebellar causes.
* Performance of a warm-up outside of the established protocol.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
"Ankle Test" with Leg Motion® (Check Your Motion®, Albacete, Spain)
Timeframe: Baseline
2
Easy Angle digital inclinometer
Timeframe: Baseline
3
"Lower Body Test" at Octobalance (Check Your Motion®, Albacete, Spain)
Timeframe: Baseline
4
Beighton Scale
Timeframe: Baseline
Trial details
NCT IDNCT07589218
SponsorBenjamín Cuenca Valero
Sponsor typeOTHER
Study typeOBSERVATIONAL
Primary completion2026-05-15
Contact for this trial
Carlos Sales Castellanos, Podología y Fisioterapia